Diabetes mellitus and cancer

European Journal of Internal Medicine

Volumn 11, Issue 5, 2000, Pages 245-252

  Czyzyk, Artur ^a   Szczepanik, Zdzislawa ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Cancer; Diabetes; Hyperinsulinism

Indexed keywords

ACARBOSE; METFORMIN;

BREAST CANCER; CANCER; CANCER LOCALIZATION; CANCER RISK; COLORECTAL CANCER; DIABETES MELLITUS; DIABETIC DIET; DISEASE ASSOCIATION; ENDOMETRIUM CANCER; EXERCISE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; KIDNEY CANCER; LIVER CANCER; MITOGENICITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS CANCER; REVIEW; RISK FACTOR;

EID: 0033797716     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0953-6205(00)00106-0     Document Type: Review

References (68)

1. Freund E. Zur Diagnose des Carcinoms. Wien med Bl. 8:1885;268-269.
2. Gilbert A., Weil E. Le cancer chez les diabètiques. Compt Rend Soc Biol. 5:1898;1121-1124.
3. Marble A. Diabetes and cancer. N Engl J Med. 211:1934;339-349.
4. Wilson E.B., Maher H.C. Cancer and tuberculosis with some comments on cancer and other diseases. Am J Cancer. 16:1932;227-246.
5. Ellinger F., Landsman H. Frequency and course of cancer in diabetics. NY State J Med. 44:1944;259-265.
6. Jacobson P.H. Statistical study of cancer among diabetics. Milkbank Meml Fund Q. 26:1948;90-118.
7. Kessler I.I. Cancer mortality among diabetics. J Natl Cancer Inst. 44:1970;673-686.
8. Ragozzino M., Melton III L.J., Chu C.-P., Palumbo P.J. Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus. J Chron Dis. 35:1982;13-19.
9. Smith G.D., Egger M., Shipley M.J., Marmot M.G. Postchallenge glucose concentration, impaired glucose tolerance, diabetes and cancer mortality. Am J Epidemiol. 136:1992;1110-1114.
10. Chow W.-H., Gridley G., Nyren O., et al. Risk of pancreatic cancer following diabetes mellitus: a nationwide cohort study in Sweden. J Natl Cancer Inst. 87:1995;930-931.
11. Wideroff L., Gridley G., Mellemkjaer L., et al. Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst. 89:1997;1360-1365.
12. Silverman D.T., Schiffman M., Everhard J., et al. Diabetes mellitus, other medical conditions and familial history of cancer as risk factors of pancreatic cancer. Br J Cancer. 80:1999;1830-1837.
13. Adami H.-O., Chow W.-H., Nyren O., et al. Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst. 88:1996;1472-1477.
14. La Vecchia C., Negri E., Decarli A., Franceschi S. Diabetes mellitus and the risk of primary liver cancer. Int J Cancer. 73:1997;204-207.
15. Weiderpass E., Gridley G., Nyren O., Ekbom A., Persson I., Adami H.-O. Diabetes mellitus and risk of large bowel cancer. J Natl Cancer Inst. 89:1997;660-661.
16. La Vecchia C., Negri E., Decarli A., Franceschi S. Diabetes mellitus and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 6:1997;1007-1010.
17. Le Marchand L., Wilkens L.R., Kolonel L.N., Hankin J.H., Lyu L.-C. Association of sedentary lifestyle, obesity, smoking, alcohol use, and diabetes with the risk of colorectal cancer. Cancer Res. 57:1997;4787-4794.
18. Will J.C., Galuska D.A., Vinicor F., Calle E.E. Colorectal cancer: an other complication of diabetes mellitus? Am J Epidemiol. 147:1998;816-825.
19. Hu F.B., Manson J.A.E., Liu S., et al. Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer. J Natl Cancer Inst. 91:1999;542-547.
20. O'Mara B., Byers T., Schoenfeld E. Diabetes mellitus and cancer risk: a multisite case-control study. J Chron Dis. 38:1985;435-441.
21. Brinton L.A., Berman M.L., Mortel R., et al. Reproductive, menstrual, and medical risk from endometrial cancer: results from a case-control study. Am J Obstet Gynecol. 167:1992;1317-1325.
22. La Vecchia C., Negri E., Franceschi S., D'Avanzo B., Boyle P. A case-control study of diabetes mellitus and cancer risk. Br J Cancer. 70:1994;950-953.
23. Maatela J., Aromaa A., Salmi T., Pohja M., Vuento M., Gronroos M. The risk of endometrial cancer in diabetic and hypertensive patients: a nationwide record linkage study in Finland. Ann Chir Gynaecol. 83:1994;20-24.
24. Weiderpass E., Gridley G., Persson I., Nyren O., Ekbom A., Adami H.-O. Risk of endometrial and breast cancer in patients with diabetes mellitus. Int J Cancer. 71:1997;360-363.
25. Lindblad P., Chow W.-H., Chan J., et al. The role of diabetes mellitus in aetiology of renal cell cancer. Diabetologia. 42:1999;107-112.
26. Breslow N.E., Day A.E. Statistical methods in cancer research. II. The design and analysis of cohort studies. IARC Sci Publ. 82:1987;1-406.
27. Everhardt J., Wright D. Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis. J Am Med Assoc. 273:1995;1605-1609.
28. Gullo L. Diabetes and risk of pancreatic cancer. Ann Oncol. 10:(Suppl 4):1999;S79-S81.
29. Sasaki A., Kamado K., Uehara M. Changes in causes of death in diabetic patients based on death certificates during a 30-year period in Osaka District, Japan, with special reference to cancer mortality. Diabetes Res Clin Pract. 24:1994;103-112.
30. Hertig A.T., Sommers S.C. Genesis of endometrial carcinoma. I. Study of prior biopsy. Cancer. 2:1949;946-955.
31. Warren S., LeCompte P.M., Legg M.A. The pathology of diabetes mellitus. 4th ed :1996;364-373 Lea and Febiger, Philadelphia.
32. Muck B.R., Trotonow S. Endometriumkarzinom und pathologische Glucosetoleranz. Arch Gynäk. 216:1974;301-310.
33. Levran D., Modan M., Menczer J., Dulitzy M. Increased rate of glucose intolerance in endometrial cancer - a community based study. Gynecol Obstet Invest. 18:1984;190-193.
34. Shoff S.M., Newcomb P.A. Diabetes, body size, and risk of endometrial cancer. Am J Epidemiol. 148:1998;234-240.
35. Troisi R., Potischman N., Hoover R.N., Sitteri P., Brinton L.A. Insulin and endometrial cancer. Am J Epidemiol. 146:1997;476-482.
36. Muck B.R., Trotonow S., Hommel G. Cancer of breast, diabetes, and pathological glucose tolerance. Arch Gynäk. 220:1975;73-81.
37. Unger C., Rageth J.C., Wyss P., Spillmann M., Hochuli E. Mammakarzinom-Risikofaktoren. Schweiz Med Wschr. 121:1991;30-36.
38. Unterburger P., Sinop A., Noder W., et al. Diabetes mellitus und Mammakarzinom. Onkologie. 13:1990;17-20.
39. Sellers T.A., Sprafka J.M., Gapstur S.M., et al. Does body fat distribution promote familial aggregation of adult onset diabetes and postmenopausal breast cancer? Epidemiology. 5:1994;102-108.
40. Sellers T.A., Anderson K.E., Olson J.E., Folsom A.R. Family histories of diabetes mellitus and breast cancer and incidence of postmenopausal breast cancer. Epidemiology. 9:1998;102-105.
41. Bruning P.F., Bonfrer J.M.G., Van Noord P.A.H., Hart A.A.M., De Jong-Baker M., Nooijen W.J. Insulin resistance and breast-cancer risk. Int J Cancer. 52:1992;511-516.
42. Schlehoffer B., Pommer W., Mellemgaard A., et al. International renal cell cancer study. VI. The role of medical and family history. Int J Cancer. 66:1996;723-726.
43. Nelson R., Persky V., Davis F., Becker E. Excess risk of primary liver cancer in patients with diabetes mellitus [letter]. J Natl Cancer Inst. 89:1997;327-328.
44. Nelson R., Persky V., Davis F. Diabetes mellitus and risk of large bowel cancer [letter]. J Natl Cancer Inst. 89:1997;1232.
45. Kirschner M.A., Ertel N., Schneider G. Obesity, hormones and cancer. Cancer Res. 41:1981;3711-3717.
46. Moller H., Mellemgaard A., Lindvig K., Olsen J.H. Obesity and cancer risk: a Danish record linkage study. Eur J Cancer. 30A:1994;344-350.
47. Hunter D.J., Willett W.C. Diet, body size, and breast cancer. Epidemiol Rev. 15:1993;110-132.
48. Ballard-Barbash R. Anthropometry and breast cancer. Body size - a moving target. Cancer. 74:1994;1090-1100.
49. Kaklamani E., Trichopoulos A., Tzonou A., et al. Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma. J Am Med Assoc. 265:1991;1974-1976.
50. Nakamura T., Imamura K., Kasai F., Tsushima F., Kukuchi H., Takebe K. Fecal excretion of hydroxy-fatty acid and bile acid in diabetic diarrheal patients. J Diabet Compl. 7:1993;8-11.
51. DuBois R.N., Gupta R., Brockman J., Reddy B.S., Krakow S.L., Lazar M.A. The nuclear eicosanoid receptor, PPAR γ, is aberrantly expressed in colonic cancers. Carcinogenesis. 19:1998;49-53.
52. Hoelting T., Duh O.Y., Clark O.H., Herfarth C. The regulation of proliferation and invasion in differentiated thyroid cancer by growth factors. Exp Clin Endocr Diabetes. 104:(Suppl 4):1996;29-31.
53. Oehler M.K., Rehn M., Kristen P., Sutterlin M., Caffier H. Correlation of the EGF-receptor with cell kinetics and classical prognostic factors in breast cancer. Anticancer Res. 17:(4B):1997;3137-3140.
54. Zhang W., Thornton W.H., MacDonald R.S. Insulin-like growth factor I and II receptor expression in rat colon mucosa are affected by dietary lipid intake. J Nutr. 128:1998;158-165.
55. Yu H., Berkel H. Insulin-like growth factors and cancer. J Louisana State Med Soc. 151:1999;218-223.
56. Nakamura T., Fukui M., Ebihara I., et al. mRNA expression of growth factors in glomeruli from diabetic rats. Diabetes. 42:1993;450-456.
57. Dandona P., Thusu K., Cook S., et al. Oxidative damage to DNA in diabetes mellitus. Lancet. 347:1996;444-445.
58. Permert J., Larsson J., Westmark G.T., et al. Islet amyloid polypeptide in patients with pancreatic cancer and diabetes. N Engl J Med. 330:1994;313-318.
59. Giovannucci E. Insulin and colon cancer. Cancer Causes Control. 6:1995;164-179.
60. Stoll B.A. Nutrition and breast cancer: can an effect via insulin resistance be demonstrated ? Breast Cancer Res Treat. 38:1996;239-246.
61. Kaaks R. Nutrition, hormones, and breast cancer: is insulin the missing link. Cancer Causes Control. 7:1996;605-625.
62. Kim Y.-I. Diet, lifestyle, and colorectal cancer: is hyperinsulinemia the missing link? Nutr Rev. 56:1998;275-279.
63. Inoue S., Fukuda K., Kudara T., et al. Augmented growth response to IGF-1 via increased IRS-1 in Chinese hamster ovary cells expressing kinase-negative insulin receptors. Diabetologia. 42:1999;763-772.
64. Bell R.H., McCullough J., Pour P.M. Influence of diabetes on susceptibility to experimental pancreatic cancer. Am J Surg. 155:1988;159-164.
65. Fisher W.E., Boros L.G., O'Dorisio T.M., O'Dorisio M.S., Schirmer W.J. GI hormonal changes in diabetes influence pancreatic cancer growth. J Surg Res. 58:1995;754-758.
66. White M.E. The insulin signalling system and the IRS proteins. Diabetologia. 40:(Suppl):1997;S2-S17.
67. Jiang Z., Lin Y.-W., Clemont A., et al. Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats. J Clin Invest. 104:1999;447-457.
68. Stout R.W. Insulin and atheroma. A 20-year perspective. Diabetes Care. 13:1990;631-655.